AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ClearPoint Neuro, Inc. Director's Dealing 2022

Aug 16, 2022

32641_dirs_2022-08-16_dc6688c5-a5ca-47ac-aa9d-abd02c761a83.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ClearPoint Neuro, Inc. (CLPT)
CIK: 0001285550
Period of Report: 2022-08-15

Reporting Person: BURNETT JOSEPH MICHAEL (Director, CEO and President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-15	Common Stock	F	7778	$16.02	Disposed	280962	Direct
2022-08-15	Common Stock	S	18867	$16.07	Disposed	262095	Direct

Footnotes

F1: Represents the amount of shares delivered to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.

F2: Includes 2,155 shares of common stock acquired through purchases pursuant to the Employee Stock Purchase Plan.

F3: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.